Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInternational Airlines Regulatory News (IAG)

Share Price Information for International Airlines (IAG)

Share Price is delayed by 15 minutes
Get Live Data
410.20    -4.30 (-1.04%)
Bid:
410.00
Ask:
410.40
Spread: 0.40 (0.098%)
Market Cap: £18.26b
IAG Live PriceLast checked at - London Stock Exchange

Intraday International Airlines Share Chart

Share purchase programme

9 May 2023 14:43

RNS Number : 8312Y
International Cons Airlines Group
09 May 2023
 

INTERNATIONAL CONSOLIDATED AIRLINES GROUP, S.A. ("IAG" or the "Company") announces that, in accordance with the authorisation granted by the Annual General Shareholders' Meeting held on 16 June 2022, it will undertake a share purchase programme (the "Programme") for the purposes of hedging its requirement to deliver shares to Globalia as part of the consideration for its proposed acquisition of the remaining 80 per cent. of the issued share capital of Air Europa.

As announced on 24 February 2023, the proposed acquisition of Air Europa is subject to regulatory and other approvals. If the proposed acquisition is not completed, the shares purchased under the Programme alternatively may be used to satisfy share awards to executives and employees (including executive directors) made under the IAG share-based incentive plans.

Deutsche Bank Aktiengesellschaft ("Deutsche Bank") has been engaged to implement the Programme. Deutsche Bank (and/or its delegates) will make the share purchases on the Company's behalf and make all trading decisions independently of, and uninfluenced by, the Company.

The Programme will have the following characteristics:

a) Regulated market: the shares will be purchased on both the London Stock Exchange and the Spanish Stock Exchanges (each an "Exchange").

b) Maximum pecuniary amount allocated to the programme: €55,000,000.

c) Maximum number of shares to be acquired: up to 27,000,000 ordinary shares, which represent 0.5 per cent. of the Company's share capital as of today's date (9 May 2023).

d) Maximum consideration per share: the shares will be purchased at a maximum price of the higher of the price of the last independent trade and the highest then current independent purchase bid on the Exchange where the purchase is carried out.

e) Maximum volume per trading session: no more than 25 per cent. of the average daily volume of the shares traded on the Exchange in the 20 trading days immediately preceding the date of purchase.

f) Duration: The Programme will start on 9 May 2023 and end no later than 14 June 2023, unless terminated by the Company or Deutsche Bank in the event of any circumstance that so advises or requires.

Shares purchased under the Programme will be held in treasury.

Nicholas Cadbury

Chief Financial Officer

 

9 May 2023 LEI: 959800TZHQRUSH1ESL13

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFFVEAIAIIV
Date   Source Headline
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20252:26 pmRNSDirector/PDMR Shareholding
5th Aug 20252:17 pmRNSDirector/PDMR Shareholding
5th Aug 20252:16 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20257:00 amRNSHalf-year Report
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20251:42 pmRNSTotal Voting Rights
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20259:45 amRNSDirector/PDMR Shareholding
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20253:28 pmRNSTotal Voting Rights
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20253:17 pmRNSDirector Declaration
19th Jun 20252:17 pmRNSDirectorate Change
19th Jun 20252:16 pmRNSDividend Declaration
19th Jun 20252:11 pmRNSResult of AGM
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 202511:55 amRNSIberia Investor Insight Day
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.